Xylovis Oral Topical Solution contains Lidocaine 21.3 mg as the active ingredient and is indicated for the temporary relief of pain and discomfort associated with oral mucosal conditions such as ulcers, sores, and minor irritations. Lidocaine is a local anesthetic that acts by blocking sodium ion channels, thereby inhibiting nerve impulse conduction and providing effective topical analgesia. Xylovis is applied directly to the affected mucosal area, producing rapid onset of numbing effect that aids in reducing pain during activities such as eating, drinking, or speaking. The solution is intended for short-term use and should be applied sparingly to avoid systemic absorption and potential toxicity. Contraindications include known hypersensitivity to lidocaine or other amide-type local anesthetics. Caution is advised in patients with severe hepatic impairment or cardiac conduction abnormalities. Adverse effects are generally mild and may include localized irritation or allergic reactions. Xylovis Oral Topical Solution should not be used on large areas or broken skin, and ingestion should be avoided. Patients are advised to follow dosing instructions carefully and consult a healthcare professional if symptoms persist or worsen. This product provides an effective, targeted approach to managing oral pain with minimal systemic exposure.